Essex Management, an Emmes Group company, has appointed David Loose as Chief Executive Officer (CEO), effective immediately.

Increases speed to market for drug developers working on nucleic acid therapeutics.

Mytos has entered into a manufacturing collaboration with Aspen Neuroscience Inc. to automate the manufacturing of autologous ...

The companies entered the agreement in 2023 to jointly advance as many as 11 drug programs, mainly targeting cardiovascular ...

Mytos, a provider of automated cell manufacturing, has entered a manufacturing collaboration with Aspen Neuroscience, Inc. to ...